Representative plots of analytes, including CXCL11, MIG, IL-6, and CRP, depict the significant reduction of expression of analytes with TB treatment from baseline, week 6/8 to end of treatment (week 24) in both PTB and PCTB groups (Figure 5C). Here, CRP is linked to tuberculosis.